A characteristic feature of many cancer types is their ability to metastasise to the skeleton.
Introduction
A characteristic feature of many cancer types is their ability to metastasise to the skeleton () . Bone is the most common site of metastatic invasion, after hematogenous spreading of breast cancer. Early detection of bone metastases is mandatory in the evaluation and managament of this patients. This is of clinical importance as metastatic bone disease is associated with increased morbidity and excess mortality (,,) . Today there are several procedures and tests available in diagnosis of breast cancer metastases. These investigations are aimed to: establish location of dissemination, make a specific diagnosis, prevent complications by early diagnosis and finally to assess patients response on treatment () . Bone scintigraphy is most commonly performed procedures in detection and evaluation of bone metastases. This investigation allows detection of osteoblastic activity with high sensitivity. Tumor markers are present in healthy individuals as well as in patients with malignant diseases but in different concentration. In brest cancer, breast-associated mucin marker Ca - is widely accepted as a serum tumor marker in follow-up and detection of disease recurrence (,) . Carcinoembrionalni antigen-CEA is protein found in many types of tumors and the developing fetus. The main use of CEA as tumor marker, especially with intenstinal cancer. CEA is also used in patient with breast and lung cancer () .
Patients and Methods
Twenty five patients with pathologically proven and previously surgically treated brest cancer were included in study. All patients underwent whole body scintigraphy using double-head gamma camera equiped with low energy high resolution collimator  hours after I.V. injection of MBq Tc-m MDP (methylen diphosponate). Ca - and CEA were measured by radioimmunoassay using microparticle Enzym-Immunoassay tehnology, (MEIA, Abbott AXSYM system). Statistical analyses were performed with chi-square test, Student t-test, standard deviation. Study was approved by Ethical Committee and informed consent in writen was obtained from all subjects in advance.
Results
Median age of patients included in study was  (Graph ). Bone scintigraphy was positive in  (  ) patients. Scintigraphy was negative for bone metastases in  (  ) patients. In  patients with positive bone scintigraphy for metastases  () patients had elevated level of Ca- and CEA (Table ) . A weak correlation was found between number of metastases and level of Ca - (r=.) (Graph ). However, statistically significant differences was found in patient with bone metastases revealed scintigraphicallay and level of Ca- in relation with patients without bone metastases (chi square , p=,) Correlation between number of metastases found by bone scintigraphy and level of tumor marker CEA was positive (r=,, p=,) (Graph ). Correlation between level of two tumor markers Ca- and CEA was a weak (r = ,, p = ,) (Graph ).
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Discussion
Bone scintigraphy as diagnostic method, has found place in many algorithms.Bone scintigraphy is sensitive for many abnormality in bone that causes an osteoblasic reaction,yet it is rather unspecific. The reasons for the success of bone scintigraphy are: the procedure is simple, relatively cheap and reliably provides relevant clinical information in the aerly phase where radiographs are frequently still normal ( ) . Clinical areas in which the bone scan has been evaluated include staging, systematic follow-up of asimptomatic patients, and assessment of response to therapy () . Tumor marker sensitivity is also related to the site of recurrence, with the lowest sensitivity for locoregional relapse and highest for liver metastases () . A rising Ca - level can detect recurrence after primary treatment,but it is not jet clear if using this test affects survival or quality of life for women with breast cancer.There can also be false positives(positive results in women with no cancer). The disease extent of patients with bone metastases correlated significantly with high Ca - levels. There were higher Ca - levels for larger disease extent (,) . In our study we found significantly higher levels of Ca - in patients presented with bone metastases, however, we found no significant correlation betwen level of Ca - and number of bone metastases.Tumor markers are useful tools for the early diagnosis of metastases,being the first sign of recurrence in ,  of patients with relapse (, in patients with metastases ) (,) .Although serial tumor marker measurements are an efficient and cost effective method of monitoring disease progresion,it does not allow prediction of the bone scan results, so it is not justifiable to reject a bone scintigraphy on the basis of these markers. In our study we found good correlation between bone metastases and serum level of CEA. We found no significant correlation between two tumor markers Ca- and CEA in patiens with breast carcinoma.
